Author: GlobeNewswire

STOUGHTON, Mass., April 07, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today…

CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) — Casma Therapeutics, Inc., a biotechnology company engaging the autophagy system to design…

CAMBRIDGE, Mass. and NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology…

WATERTOWN, Mass., April 06, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta” or the “Company”), a biotechnology company…

CAMBRIDGE, Mass., April 06, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced publication in The New England Journal…

Biomea to present additional preclinical data from an in vivo study of BMF-219 in type 2 diabetes REDWOOD CITY, Calif., April…

Meeting Scheduled for April 8, 2022 at 9:00 AM ET NEW YORK, NY, April 06, 2022 (GLOBE NEWSWIRE) — Enzo…

OSLO, Norway and DALLAS, April 06, 2022 (GLOBE NEWSWIRE) — The Coalition for Epidemic Preparedness Innovations (CEPI) and Vaxxinity, Inc.…

MOUNTAIN VIEW, Calif., April 06, 2022 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (NASDAQ: IGMS) today announced the closing on April…

PHILADELPHIA, April 06, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell…